You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 10, October 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Long-term Therapeutic Use of Benzodiazepines

II. Effects of Gradual Taper

Edward Schweizer, MD; Karl Rickels, MD; W. George Case, MD; David J. Greenblatt, MD

Arch Gen Psychiatry. 1990;47(10):908-915.


Abstract

• We compared the effect on withdrawal severity and acute outcome of a 25% per week taper of short half-life vs long half-life benzodiazepines in 63 benzodiazepine-dependent patients. Patients unable to tolerate taper were permitted to slow the taper rate. Ninety percent of patients experienced a withdrawal reaction, but it was rarely more than mild to moderate. Nonetheless, 32% of long half-life and 42% of short half-life benzodiazepinetreated patients were unable to achieve a drug-free state. The most difficulty was experienced in the last half of taper. Baseline personality, high Eysenck neuroticism, female sex, and mild-tomoderate alcohol use were found to be more significant predictors of withdrawal severity than the daily benzodiazepine dose or benzodiazepine half-life. These findings suggest that personality factors contribute significantly to the patient's difficulties with gradual benzodiazepine discontinuation of therapeutic doses of benzodiazepines.



Footnotes

Accepted for publication November 29, 1989.

From the Psychopharmacology Research Unit, Department of Psychiatry, University of Pennsylvania, Philadelphia (Drs Schweizer, Rickels, and Case), and the Division of Clinical Pharmacology, Departments of Psychiatry and Pharmacology, Tufts University School of Medicine and New England Medical Center, Boston, Mass (Dr Greenblatt).

Reprint requests to 203 Piersol Bldg, University Hospital, 3400 Spruce St, Philadelphia, PA 19104 (Dr Rickels).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Strategies for discontinuing long-term benzodiazepine use: Meta-analysis
Voshaar et al.
Br. J. Psychiatry 2006;189:213-220.
ABSTRACT | FULL TEXT  

Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice
Gorgels et al.
Fam Pract 2006;23:65-72.
ABSTRACT | FULL TEXT  

Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors
Nutt
J Psychopharmacol 2003;17:355-364.
ABSTRACT  

Gradual reduction of benzodiazepines, with or without cognitive behavioural therapy, increases successful withdrawal rates compared with no support in long-term users
Boyce
Evid. Based Ment. Health 2003;6:119-119.
FULL TEXT  

Hypnotic Dependent Insomnia in an Older Adult with Addiction-Prone Personality
Cooper et al.
Clinical Case Studies 2003;2:247-258.
ABSTRACT  

Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial
VOSHAAR et al.
Br. J. Psychiatry 2003;182:498-504.
ABSTRACT | FULL TEXT  

Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off: Report on behalf of the Dutch Chronic Benzodiazepine Working Group
ZITMAN and COUVEE
Br. J. Psychiatry 2001;178:317-324.
ABSTRACT | FULL TEXT  

Imipramine and Buspirone in Treatment of Patients With Generalized Anxiety Disorder Who Are Discontinuing Long-Term Benzodiazepine Therapy
Rickels et al.
Am. J. Psychiatry 2000;157:1973-1979.
ABSTRACT | FULL TEXT  

Interruption of selective serotonin reuptake inhibitor treatment: Double-blind, placebo-controlled trial
MICHELSON et al.
Br. J. Psychiatry 2000;176:363-368.
ABSTRACT | FULL TEXT  

Addiction to Benzodiazepines--How Common?
Piper
Arch Fam Med 1995;4:964-970.
ABSTRACT  

Maintenance Drug Treatment of Panic Disorder: I. Results of a Prospective, Placebo-Controlled Comparison of Alprazolam and Imipramine
Schweizer et al.
Arch Gen Psychiatry 1993;50:51-60.
ABSTRACT  

Maintenance Drug Treatment for Panic Disorder: II. Short- and Long-term Outcome After Drug Taper
Rickels et al.
Arch Gen Psychiatry 1993;50:61-68.
ABSTRACT  

Prescription Drug Diversion Control and Medical Practice
Cooper et al.
JAMA 1992;268:1306-1310.
ABSTRACT  

Carbamazepine Treatment in Patients Discontinuing Long-term Benzodiazepine Therapy: Effects on Withdrawal Severity and Outcome
Schweizer et al.
Arch Gen Psychiatry 1991;48:448-452.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.